Mitchell has almost 20 years’ experience in the investment industry, with a specific focus on investment marketing and communications. At Invesco Perpetual, he was a key member of on the UK equities team, assisting Neil in articulating his investment philosophy, approach and strategy to intermediaries and institutional clients.
He is a great believer in open, honest dialogue with investors and is experienced in communicating complex financial concepts in simple and accessible terms. Mitchell feels strongly that investors are entitled to know how their investments are being managed and is committed to making sure Woodford’s clients are well informed.
May was another positive, albeit increasingly volatile, month for UK equities. Dollar strength is becoming an increasingly important feature of the market backdrop, in response to the deteriorating global liquidity conditions. This is playing out most aggressively in emerging markets thus far and political events in Italy have brought the eurozone’s frailties back to the forefront of investors’ minds…
Following the trial failure announcement from Prothena, today marks the release of the Woodford Patient Capital Trust annual report for 2017. Neil’s review reflects yesterday’s news but as you will read, it should not detract from the progress being demonstrated across much of the rest of the portfolio. The full annual report can also be